☆ 4.7 Letter

REPLY: What Is Important for Digoxin Treatment in Patients With Heart Failure

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Get Full Text
Add to Collection

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 74, Issue 22, Pages 2827-2828

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2019.09.047

Keywords

-

Categories

Cardiac & Cardiovascular Systems

Funding

  1. National Institutes of Health [R01-HL085561, R01-HL085561-S]
  2. National Heart, Lung, and Blood Institute [R01-HL097047]
  3. GlaxoSmithKline
  4. Novartis

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.